Corticosteroid is
a class of steroidal hormone, which is produced in adrenal cortex and is used
to care for several diseased conditions for instance renal disease, cerebral
edema, autoimmune disease, GIT disease, skin disease, and others. In addition,
naturally occurring corticosteroids are produced by the external portion of the
adrenal gland (two small glands that sit on peak of the kidneys) recognized as
the cortex. Additionally, steroids are used in organ transplantation &
replacement therapy. The hormones may be injected, orally, inhaled or applied
topically. Injected corticosteroids are used treating a specific location like inflammation
or pain attributable to tendinitis in a joint. The oral corticosteroids are
used to treat and help in control symptoms of chronic conditions like
rheumatoid arthritis, by reducing the inflammation of the body. Corticosteroids
are inhaled to care asthma by reducing the inflammation & swelling of the
airways, can also aid lower the risk & frequency of future attacks.
Corticosteroid is often
used as an anti-inflammatory prescriptions and immune suppressants to treat
asthma, arthritis, autoimmune diseases (lupus & multiple sclerosis), some
types of cancer (leukemia), skin conditions (eczema and psoriasis), and the
aftermath of organ transplant. Furthermore, some associated side effects are glaucoma,
high blood pressure, fluid retention, and weight gain. These side effects are
typically minimized by rinsing & gargling with water, without swallowing,
to patent any enduring medication. Some examples are included betamethasone,
prednisolone, prednisone, methylprednisolone, triamcinolone, and dexamethasone.
According to
study, “Global Steroid-Corticosteroids
Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024” the major companies currently operating
in the global steroid-corticosteroids market are Sumitomo Corp., Novartis, Pfizer
Inc., Merck& Co. Inc., Abbott Laboratories, Johnson and Johnson, Sanofi,
AstraZeneca, GlaxoSmithKline (GSK) Plc., Cipla.
Based on product
type, global steroid-corticosteroids market is segmented into injection, cream,
and others. Based on class, market is categorized into mineralocorticoids (salt retaining) and
glucocorticoids (anti-inflammatory). Mineralocorticoids regulate balance of
salt & water in the body. Glucocorticoids suppress inflammation & immunity
and help in the breakdown of carbohydrates, fats, and proteins. Based on forms,
market is classified as injections form, lotions & gels forms or creams,
tablets forms and inhalers forms. Based on application, market is segmented
into chemotherapy, motion sickness, pregnancy, food poisoning, dizziness, gastroenteritis,
general anesthetics, emotional stress, opioid analgesics and others. Based on
end-use industries, the market is categorized into clinics, hospitals and
others.
The global
steroid-corticosteroids are primarily driven by rise in drug resistance,
increase in prevalence of chronic & infectious diseases and low cost of
products and rise in therapeutical product application. However, side effects
related with corticosteroids (for instance cataract, thinning bones, high blood
sugar, and high risk of infections) are the major restrains for the market
growth.
The global
steroid-corticosteroids market are expected to grow at a CAGR of approximately
4.3% over the over the forecast period, and expected to reach US $5130 million
in 2024, from US $3980 million in 2019.
For more
information, refer to below link:-
Related
Report:-
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249
No comments:
Post a Comment